🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate how well the effectiveness of the medicine Taze...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07282548
The purpose of this research study is to learn about the effectiveness and ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-09-02
Trial ID
NCT06068881
Treatments Being Tested
This research is being done to evaluate tazemetostat in combination with CH...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12-24
Trial ID
NCT06692452
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of combina...
Status
Active Not Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2023-03-01
Trial ID
NCT05627245
This trial will study how safely the tazemetostat works with other therapie...
Status
Withdrawn
Location
California Cancer Associates For Research And Excellence, cCARE
Start Date
2021-12-22
Trial ID
NCT05205252
This main aim of this trial will be to study the blood levels (known as pha...
Status
Terminated
Location
Florida Cancer Specialists & Research Institute
Start Date
2020-01-15
Trial ID
NCT04241835
Treatments Being Tested
The FDA approved targeted agent tazemetostat inhibits EZH2 and induces dura...
Status
Terminated
Location
Prisma Health Cancer Institute
Start Date
2022-01-06
Trial ID
NCT05023655
Treatments Being Tested
This study will provide continuing availability to tazemetostat for people ...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2016-08-30
Trial ID
NCT02875548
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of repurposi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-01
Trial ID
NCT05018975
Treatments Being Tested
A phase II clinical study of tazemetostat combined with HMPL-689 in patient...
Status
Completed
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2023-02-13
Trial ID
NCT05713110
Treatments Being Tested